TREATMENT OF ATYPICAL MYCOBACTERIAL DISEASE

被引:34
作者
BAILEY, WC [1 ]
机构
[1] UNIV ALABAMA,SCH MED,BIRMINGHAM,AL 35233
关键词
D O I
10.1378/chest.84.5.625
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
引用
收藏
页码:625 / 628
页数:4
相关论文
共 27 条
[1]  
AHN CH, 1976, AM REV RESPIR DIS, V113, P273
[2]  
AHN CH, 1981, REV INFECT DIS, V3, P1028
[3]  
CHRISTENSEN EE, 1981, CHEST, V30, P132
[4]   CLINICAL ASPECTS, MEDICAL AND SURGICAL, IN THE MANAGEMENT OF BATTEY-TYPE PULMONARY DISEASE [J].
CORPE, RF .
DISEASES OF THE CHEST, 1964, 45 (04) :380-382
[5]  
DALOVISIO JR, 1981, REV INFECT DIS, V3, P1068
[6]  
DAVIDSON PT, 1981, REV INFECT DIS, V3, P1052
[7]   DYNAMIC ASPECTS OF THE ACTIVITY OF CLOFAZIMINE AGAINST MYCOBACTERIUM-INTRACELLULARE [J].
GANGADHARAM, PR ;
PRATT, PF ;
DAMLE, PB ;
DAVIDSON, PT .
TUBERCLE, 1981, 62 (03) :201-206
[8]   INVITRO SUSCEPTIBILITY OF ATYPICAL MYCOBACTERIA TO CEPHALOSPORINS [J].
GARCIARODRIGUEZ, JA ;
MARTINLUENGO, F .
TUBERCLE, 1980, 61 (01) :39-40
[9]  
GERNEZRIEUX C, 1959, B UNION INT TUBERC, V29, P330
[10]  
GOOD RC, 1979, CDC NEWS, P779